Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Acquisition - Replacement

5th Apr 2006 15:19

International Medical Devices PLC05 April 2006 International Medical Devices Plc wishes to announce that the announcementreleased earlier today under RNS No 0389B incorrectly stated that an applicationhad been made for the total of 37,329,000 new ordinary shares to be admitted toAIM. This figure did not include the 40,000,000 new ordinary shares to be issuedto the vendors of RME so the correct total figure should be 77,329,000 newordinary shares. INTERNATIONAL MEDICAL DEVICES PLC SUCCESSFUL FUND RAISING AND ACQUISITION - £1.769 million of new equity raised via private placement and from existing warrant holders - Acquisition of Response Medical Equipment Ltd for £6.3 million (including £1 million earn-out) - Acquisitions transforms IMD Plc into a £8.5 million turnover business with historic pro-forma consolidated profits before tax of £800,000 - IMD Plc strengthens management team. - Response Medical Equipment provides channels to NHS market for safe needle products. International Medical Devices Plc (IMD) is pleased to announce that it hasentered into an unconditional agreement with Response Medical Equipment Ltd(RME) to acquire the whole of its issued share capital. The total considerationfor this acquisition is £6.3 million payable as follows: £1.5 million in cash oncompletion with the balance payable by 30 June 2006 subject to tradingperformance indicators, £2.8 million payable in shares issued at 7p per share(40 million shares), £500,000 in deferred loan notes repayable on first andsecond anniversary of the transaction in tranches of £250,000, plus in additionan earn-out of £1 million payable in shares over a period of 3 years dependenton the achievement of predetermined targets for the profit before tax in each ofthe two financial years following the acquisition. The first £200,000 is setagainst targets for 31st March 2006. In order to satisfy the cash element of the consideration, Rowan Dartington hasplaced 29,524,000 new ordinary shares in the Company with investors at 5p pershare and certain of the Company's existing shareholders have exercised warrantsto subscribe for 7,805,000 new ordinary shares at 3.75p per share. The totalraised in new equity is £1,768.888. Application has been made for the total of77,329,000 new ordinary shares to be admitted to AIM and it is expected thatadmission will take place on 6 April 2006. RESPONSE MEDICAL EQUIPMENT LTD RME is a distributor of medical devices and medical consumables. Its keydistribution agreements are with Welch Allyn, Ypsomed, Dr Comfort, Tyco, Medisand Medicapteurs. In its last audited accounts to 31st March 2005, RME achievedsales of £6.1 million generating profits before tax of £895,000. As at 31stMarch 2005, RME had net assets of £2.15 million including cash of £300,000. RME employs 19 people and has developed into an efficient, profitable,disciplined sales organisation. Of the 4 directors/shareholders, two will bejoining the main board of IMD Plc, John Butler, Chairman and founder of RME andMatthew Root, its managing director. RME sells into every NHS trust hospital in the UK, and also wins regular centraltenders from the NHS Purchasing and Supply Agency. Sales are also made tovarious ambulance services, the Ministry of Defence and to the private healthsector. IMD Plc will now have the channel to market to supply its range of "safe" needle devices and an exclusive wider product range that includes beds andhospital furniture, speciality needles, thoracic drains and sundry disposables.The IMD Plc Board is satisfied that the acquisition of RME on top of theacquisition of Meddis Ltd last September, will provide the Group with the salesskills, logistic know-how and management expertise in the medical device sectorto rapidly grow revenues and profits in the years ahead. About IMD: International Medical Devices Plc was admitted to AIM in November 2004 with thepurpose of acquiring companies or businesses operating the health and medicaldevices sector which have the prospect of delivering high return and significantcapital growth. On July 18, 2005 an Extraordinary General Meeting approved a placing whichraised £750,000 before expenses. The meeting also approved the acquisition ofthe technology patents and distribution rights ETA and EMS respectively. ETA andEMS are established Australian companies with manufacturing and distributionrights and technology rights primarily in the Southern hemisphere but also inNorth America, the UK and most of Europe. Contact: Alan Frame, Westport Communications Ltd 020 405 7777 07850944187 Chris Thomas, International Medical Devices Plc 020 7659 5216 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,419.95
Change-32.73